Gobbi G
Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
ArticlePsychedelics
Sex-sensitive serotonergic signaling in psychedelic pharmacology.
ArticleKetamine
Global perspectives on central nervous system drug innovation: achievements, barriers, and priorities for the next decade.
ArticlePsilocybin
Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.
ArticlePsilocybin
High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.
ArticleLSD
Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT<sub>2A</sub> receptor.
ArticlePsilocybin
CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.
ArticlePsychedelics
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
ArticlePsychedelics
The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics.
ArticleLSD
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence.
ArticleLSD
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
ArticlePsilocybin
Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
ArticleKetamine
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs.
ArticleLSD
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.
ArticleLSD
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.
ArticlePsilocybin
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.
ArticleLSD
Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT2A and ampa in the medial prefrontal cortex (MPFC)
ArticleLSD
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice.
ArticleLSD
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.
ArticlePsilocybin
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.
ArticlePsilocybin
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.
ArticlePsilocybin
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
ArticleLSD